Goodmans LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Goodmans LLP's intellectual property group has a strong foundation in patent litigation allowing it to advise on complex patent proceedings for the life sciences and pharmaceutical industries. The firm has aided clients with patent proceedings involving Patented Medicines (Notice of Compliance) Regulations in front of the Federal Court since its founding and boasts a wealth of expertise in Canadian and international pharmaceutical issues. Typical issues the team advises on includes pricing regulations and best practices as well as assisting clients with gaining regulatory approval. Harry Radomski and Andrew Brodkin co-lead the Toronto team and are both well-versed in handling patent litigation for life sciences clients. Jordan Scopa excels at patent litigation and has dedicated specialized appellate practice.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The Goodmans IP litigation team is extremely savvy in managing complex patent litigation. They are led by Harry Radomski and Andrew Brodkin, who have unparalleled drug patent trial experience going back to the 1980s and 1990s. They have raised a new generation of litigators, including Sandon Shogilev, Ben Hackett and Jordan Scopa, who are capable of managing major matters with minimal oversight.’
Key clients
- Sandoz Canada
- Alvotech
Work highlights
Advised Pharmascience on the issue of the patentability of methods of medical treatment in a patent matter relating to a patent covering a dosing regimen for paliperidone palmitate.